AtonRa Partners’s DexCom DXCM Stock Holding History

AtonRa Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.03M	Sell	8,296 -647	-7%	-$66.1K	2.05%	1
2023 Q3	$834K	Sell	8,943 -212	-2%	-$23.9K	1.75%	3
2023 Q2	$1.18M	Sell	9,155 -3,387	-27%	-$410K	1.82%	5
2023 Q1	$1.46M	Sell	12,542 -1,764	-12%	-$197K	2.13%	5
2022 Q4	$1.62M	Sell	14,306 -1,115	-7%	-$122K	2.06%	5
2022 Q3	$1.24M	Buy	15,421 +897	+6%	+$76K	1.22%	20
2022 Q2	$1.08M	Sell	14,524 -6,368	-30%	-$581K	0.99%	37
2022 Q1	$2.67M	Sell	20,892 -8,184	-28%	-$895K	1.45%	17
2021 Q4	$3.9M	Sell	29,076 -3,740	-11%	-$537K	1.36%	25
2021 Q3	$4.49M	Buy	32,816 +3,112	+10%	+$392K	1.5%	17
2021 Q2	$3.17M	Buy	29,704 +10,952	+58%	+$1.05M	1.16%	32
2021 Q1	$1.69M	Buy	18,752 +7,964	+74%	+$748K	0.75%	54
2020 Q4	$997K	Buy	+10,788	New	+$963K	0.49%	65

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AtonRa Partners's DXCM Position: Q4 2023 in Review

AtonRa Partners reduced its DexCom (DXCM) stake by 7.2% in Q4 2023, selling an estimated $66.1K and leaving 8,296 shares worth $1.03M. The position accounts for 2.05% of the portfolio, ranked #1.

AtonRa Partners first reported a position in DXCM in Q4 2020 and has held it in 13 quarters since. The position peaked at $4.49M in Q3 2021. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

AtonRa Partners held 8,296 shares of DexCom worth $1.03M as of Q4 2023.
AtonRa Partners sold 647 DexCom shares in Q4 2023, an estimated $66.1K.
DexCom made up 2.05% of AtonRa Partners's portfolio in Q4 2023, its #1 holding.
AtonRa Partners first reported a position in DexCom in Q4 2020 and has held it in 13 quarters since.
AtonRa Partners's DexCom position peaked at $4.49M in Q3 2021.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.